These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10225323)

  • 1. Effects of short-chain fatty acids on in vitro bacterial growth of Bacteroides fragilis and Escherichia coli.
    Mortensen FV; Møller JK; Hessov I
    APMIS; 1999 Feb; 107(2):240-4. PubMed ID: 10225323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of short-chain fatty acids produced by anaerobic bacteria on procoagulant activity produced by Escherichia coli and Bacteroides fragilis-stimulated leucocytes: possible role in intra-abdominal abscess formation.
    Miragliotta G; Mosca A; Minoia GM; Del Prete R
    Microbios; 1993; 75(305):233-40. PubMed ID: 8255254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Aloe vera whole leaf extract on short chain fatty acids production by Bacteroides fragilis, Bifidobacterium infantis and Eubacterium limosum.
    Pogribna M; Freeman JP; Paine D; Boudreau MD
    Lett Appl Microbiol; 2008 May; 46(5):575-80. PubMed ID: 18363656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of Neisseria gonorrhoeae produced in liquid medium by Bacteroides fragilis and Eubacterium limosum.
    Morin A; Saheb SA; Bisaillon JG; Beaudet R; Sylvestre M
    Microbios; 1982; 34(135):31-40. PubMed ID: 6815429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of low levels of ciprofloxacin on a chemostat model of the human colonic microflora.
    Carman RJ; Woodburn MA
    Regul Toxicol Pharmacol; 2001 Jun; 33(3):276-84. PubMed ID: 11407931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of short-chain fatty acid production.
    Macfarlane S; Macfarlane GT
    Proc Nutr Soc; 2003 Feb; 62(1):67-72. PubMed ID: 12740060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coli.
    Schaumann R; Blatz R; Beer J; Ackermann G; Rodloff AC
    J Antimicrob Chemother; 2004 Feb; 53(2):318-24. PubMed ID: 14729746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Trends in antimicrobial resistance of Pseudomonas aeruginosa, Escherichia coli and Bacteroides fragilis (1997-2001)].
    García-Rodríguez JA; Casal M; Rodríguez F;
    Rev Esp Quimioter; 2003 Dec; 16(4):421-7. PubMed ID: 14961136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of short-chain fatty acids and extracellular pH on bovine neutrophil function in vitro.
    Mills SW; Montgomery SH; Morck DW
    Am J Vet Res; 2006 Nov; 67(11):1901-7. PubMed ID: 17078753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
    Schaumann R; Petzold S; Fille M; Rodloff AC
    Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro stimulation of Bacteroides fragilis growth by Escherichia coli.
    Hagen JC; Wood WS; Hashimoto T
    Eur J Clin Microbiol; 1982 Dec; 1(6):338-43. PubMed ID: 6761111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of incubation time and medium composition on fatty acid production by some Bacteroides species.
    Salt WG; Samara MA; Stretton RJ
    Microbios; 1985; 42(171S):273-85. PubMed ID: 2863739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of the metabolic by-products of a Veillonella species and Bacteroides fragilis.
    Hinton A; Hume ME
    Anaerobe; 1995 Apr; 1(2):121-7. PubMed ID: 16887516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A decisive period in cefoxitin prophylaxis of experimental synergistic wound infection produced by Bacteroides fragilis and Escherichia coli.
    Shapiro M; Sacks T
    Isr J Med Sci; 1982 Aug; 18(8):863-5. PubMed ID: 6749759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteroides fragilis group in non-diarrheal human feces and its antimicrobial susceptibility].
    Rodríguez E; Gamboa MM; Rodríguez C; Vargas P
    Rev Esp Quimioter; 2006 Dec; 19(4):357-62. PubMed ID: 17235405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of phagocytosis of E. coli by B. fragilis group--an in vitro study.
    Beena VK; Kumari N; Shivananda PG
    Indian J Pathol Microbiol; 1997 Jul; 40(3):373-6. PubMed ID: 9354011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elimination patterns of Escherichia coli and bacteroides fragilis from the peritoneal cavity. Studies with experimental peritonitis in pigs.
    Nyström PO; Skau T
    Acta Chir Scand; 1983; 149(4):383-8. PubMed ID: 6351520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial effect of amniotic fluid.
    Thadepalli H; Bach VT; Davidson EC
    Obstet Gynecol; 1978 Aug; 52(2):198-204. PubMed ID: 355963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propionibacterium acidipropionici CRL1198 influences the production of acids and the growth of bacterial genera stimulated by inulin in a murine model of cecal slurries.
    Lorenzo-Pisarello MJ; Gultemirian ML; Nieto-Peñalver C; Perez Chaia A
    Anaerobe; 2010 Aug; 16(4):345-54. PubMed ID: 20451635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of fatty acids from lipopolysaccharides of Bacteroides thetaiotaomicron and Bacteroides fragilis].
    Rokosz A; Meisel-Mikołajczyk F; Kot K; Mieszała M; Szponar B; Gamian A
    Med Dosw Mikrobiol; 2001; 53(2):177-83. PubMed ID: 11757427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.